HAE Logo

Haemonetics Corporation (HAE) 

NYSE
Market Cap
$4.1B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
454 of 963
Rank in Industry
27 of 49

Largest Insider Buys in Sector

HAE Stock Price History Chart

HAE Stock Performance

About Haemonetics Corporation

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Insider Activity of Haemonetics Corporation

Over the last 12 months, insiders at Haemonetics Corporation have bought $0 and sold $3.46M worth of Haemonetics Corporation stock.

On average, over the past 5 years, insiders at Haemonetics Corporation have bought $323,720 and sold $6M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,000 shares for transaction amount of $323,720 was made by ABERNATHY ROBERT E (director) on 2020‑08‑11.

List of Insider Buy and Sell Transactions, Haemonetics Corporation

2024-07-26SalePresident, Global Hospital
4,312
0.0085%
$91.15$393,039-15.79%
2024-07-12SaleEVP, Chief Technology Officer
79
0.0002%
$90.00$7,1100.00%
2024-07-11SaleEVP, Chief Technology Officer
2,136
0.0045%
$90.00$192,2400.00%
2024-05-29SaleEVP and General Counsel
12,990
0.0257%
$88.08$1.14M-6.56%
2024-05-29SalePresident, Global Hospital
8,857
0.0174%
$87.53$775,253-6.56%
2024-05-20SaleEVP and General Counsel
1,604
0.0032%
$95.08$152,508-12.75%
2024-05-20SaleEVP, Global Manufacturing
987
0.0019%
$95.08$93,844-12.75%
2024-05-20SalePresident, Global Hospital
686
0.0013%
$95.11$65,245-12.75%
2024-05-17SaleEVP and General Counsel
1,073
0.0021%
$95.00$101,935-12.96%
2024-05-17SaleEVP, Global Manufacturing
822
0.0016%
$94.82$77,942-12.96%
2024-05-16SaleEVP and General Counsel
985
0.002%
$96.14$94,698-12.11%
2024-05-16SaleEVP, Global Manufacturing
770
0.0015%
$96.14$74,028-12.11%
2024-05-16SalePresident, Global Hospital
733
0.0015%
$96.04$70,397-12.11%
2024-05-06SaleEVP, Chief Technology Officer
2,305
0.0045%
$95.00$218,975-11.96%
2023-09-12SalePresident, Global Hospital
228
0.0005%
$90.65$20,668-5.52%
2023-09-11SaleEVP, Chief Technology Officer
2,305
0.0045%
$90.00$207,450-6.34%
2023-09-05Saledirector
10,215
0.0202%
$87.68$895,651-2.33%
2023-07-18SaleEVP, Global Manufacturing
4,928
0.0095%
$90.00$443,520-6.13%
2023-06-07SalePresident, Global Hospital
2,538
0.005%
$88.04$223,446-2.38%
2023-05-30SaleEVP, Chief Technology Officer
2,304
0.0045%
$83.33$191,992+2.78%

Insider Historical Profitability

5.46%
Basil Michelle LEVP and General Counsel
31257
0.0622%
$81.62031
Lingamneni AnilaEVP, Chief Technology Officer
21331
0.0425%
$81.6209
Llorens JosepEVP, Global Manufacturing
21310
0.0424%
$81.62014
Strong Stewart WPresident, Global Hospital
18196
0.0362%
$81.6209
Simon, ChristopherPresident & CEO
213724
0.4255%
$81.62121+13.41%
CONCANNON BRIANPresident & CEO
147040
0.2928%
$81.62857+8.69%
GELBMAN RONALD Gdirector
48384
0.0963%
$81.62116+4.67%
LINDOP CHRISTOPHER JCFO & EVP Business Development
45350
0.0903%
$81.621215+4.66%
ALLEN PETER MPresident, Global Plasma
34102
0.0679%
$81.622022+7.23%
MEELIA RICHARD Jdirector
32050
0.0638%
$81.6204
White JonathanChief Science and Technology
30507
0.0607%
$81.6275+3.73%
Burke William P. Mr.EVP, Chief Financial Officer
30291
0.0603%
$81.62026
FOOTE SUSAN BARTLETTdirector
20740
0.0413%
$81.6219<0.0001%
HANLON SUSAN MVP Finance
20464
0.0407%
$81.621820+5.11%
Jesse SandraEVP and Chief Legal Officer
20096
0.04%
$81.6232+5.46%
MERRIMAN RONALDdirector
17807
0.0355%
$81.6219<0.0001%
FORISH JOSEPH JVP, Human Resources
17279
0.0344%
$81.62910+4.98%
Davies Kent JChief Operating Officer
16891
0.0336%
$81.6202
KROLL MARK W
16231
0.0323%
$81.62010
Burns Brian REVP, Global QA/RA
16235
0.0323%
$81.6201
EBBELING ROBERT BVice President, Operations
15849
0.0316%
$81.6294+6.35%
GRANADILLO PEDRO Pdirector
15335
0.0305%
$81.62413+2.48%
Ryding Neil Mr.EVP, Global Manufacturing
15226
0.0303%
$81.6204
Miller Laurie A.SVP, Human Resources
12697
0.0253%
$81.6206
Granville WilliamVP, Manufacturing
12188
0.0243%
$81.6210+4.75%
ABERNATHY ROBERT Edirector
12048
0.024%
$81.6210+18.77%
Selman ByronPresident, Global Markets
12010
0.0239%
$81.6202
LOPEZ ALICIA RVP, Corporate Affairs
11017
0.0219%
$81.621324+4.9%
Kelly Michael PPresident, Global Markets
10987
0.0219%
$81.62011
BEST LAWRENCE Cdirector
10001
0.0199%
$81.6217+0.57%
NUTTER BRADChairman of the Board
9387
0.0187%
$81.62111+26.67%
Nighan Warren JRVP WW Q&R Affairs
7908
0.0157%
$81.6202
Helsel DaveEVP, Global Manufacturing
6856
0.0137%
$81.6220+2.96%
McDaniel KathleenEVP Global Human Resources
5013
0.01%
$81.6201
Popovsky Mark AVP, Corporate Medical Director
4891
0.0097%
$81.6275+4.13%
Goldstein DanVP, Corporate Controller
4447
0.0089%
$81.62040
Gordon MikaelPresident, Global Markets
4442
0.0088%
$81.6235+6.2%
Scanlan JacquelineSVP, Global Human Resources
4216
0.0084%
$81.62024
Still William RocheVP & Gen Mrg, Therapeutics Bus
4193
0.0083%
$81.6262+1.45%
O'Shaughnessy James
3781
0.0075%
$81.6210+4.75%
Brancazio Phillip JohnVP, Global Manufacturing
3052
0.0061%
$81.6230+0.64%
SWENSON STEPHENVP & General Mgr, Global Plasm
3024
0.006%
$81.6212+4.75%
Pare Anthony
2523
0.005%
$81.6212+4.75%
SAKURADA YUTAKAPresident, Japan & Asia
2347
0.0047%
$81.6220+16.87%
Dockendorff Charles Jdirector
2226
0.0044%
$81.6202
RYAN RONALD JVP and CFO
2101
0.0042%
$81.6254+5.1%
BEUCLER MARK
1989
0.004%
$81.6210+4.75%
Bolorforosh SaidEVP, Chief Technology Officer
1977
0.0039%
$81.6203
WILLIAMSON DONNA C Edirector
1300
0.0026%
$81.6204
Conneely JanVP & GM, Arryx, Inc.
1041
0.0021%
$81.6210+4.75%
ECKERT ULRICHPresident, Europe & Latin Am
890
0.0018%
$81.6224+2.88%
Corlin RemiPresident, Asia
884
0.0018%
$81.6202
Hattori KeikoPresident, Haemonetics Japan
716
0.0014%
$81.6210+4.75%
RUXIN MICHAEL IVP Global Software Strategies
215
0.0004%
$81.6210+6.76%
Sakai RyojiPresident, Japan
0
0%
$81.6203
Lawlor ThomasPresident, Patient Division
0
0%
$81.6201

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Capital Research Global Investors$569.69M13.136.67M+2.32%+$12.9M0.13
BlackRock$510.77M11.775.98M-0.92%-$4.75M0.01
The Vanguard Group$460.66M10.625.4M-0.17%-$766,357.650.01
Wellington Management Company$364.52M8.44.27M+30.68%+$85.59M0.06
Neuberger Berman$323.28M7.453.79M+7.28%+$21.93M0.27
State Street$156.38M3.61.83M+2.38%+$3.63M0.01
Franklin Templeton Investments$118.95M2.741.39M-17.73%-$25.63M0.04
ROYCE & ASSOCIATES INC$108.11M2.491.27M+31.07%+$25.63M0.96
T Rowe Price Investment Management Inc$103.97M2.41.22M+11.53%+$10.75M0.06
Geode Capital Management$96.07M2.211.13M+3.72%+$3.44M0.01
Dimensional Fund Advisors$78.61M1.81921,070+11.41%+$8.05M0.02
Boston Trust Walden Corp$60.76M1.4711,865-0.64%-$392,695.340.44
Westfield Capital Management Co Lp$59.73M1.38699,861-1.71%-$1.04M0.31
Fisher Asset Management Llc$59.58M1.37698,040-1.92%-$1.16M0.03
Schroder Investment Management Group$53.6M1.24628,019-4.38%-$2.46M0.06
Northern Trust$49.11M1.13575,410-8.45%-$4.53M0.01
T. Rowe Price$48.01M1.11562,454+38.61%+$13.37M0.01
Charles Schwab$46.67M1.08546,785+2.26%+$1.03M0.01
Allspring Global Investments$42.93M0.99502,993+132.76%+$24.49M0.07
BNY Mellon$41.58M0.96487,226-5.69%-$2.51M0.01
Silvercrest Asset Management Group Inc$38.71M0.89453,494New+$38.71M0.27
Boston Partners$38.3M0.87444,180-37.21%-$22.7M0.05
Royal Bank of Canada$34.63M0.8405,797+125.16%+$19.25M0.01
Millennium Management LLC$27.82M0.64325,998+125.28%+$15.47M0.02
Aristotle Capital Boston LLC$27.44M0.63321,526+5.32%+$1.39M0.83
Morgan Stanley$26.7M0.62312,878-28.87%-$10.84M<0.01
Bank of America$24.59M0.57288,092+78.76%+$10.83M<0.01
Ameriprise Financial$23.26M0.54272,500-5.07%-$1.24M0.01
HERITAGE ASSET MANAGEMENT INC$22.19M0.52261,673-3.98%-$920,225.840.11
CalPERS$20.32M0.47238,101+3.65%+$715,574.390.01
Heartland Advisors Inc$18.7M0.43219,065-1.19%-$224,641.200.12
Fidelity Investments$16.76M0.39196,329-87.58%-$118.16M<0.01
JPMorgan Chase$16.52M0.38193,565+9.77%+$1.47M<0.01
Victory Capital Management Inc$16.23M0.37190,127-8.3%-$1.47M0.02
Nuveen$15.35M0.35179,867+0.03%+$5,206.35<0.01
London Co Of Virginia$15.29M0.35179,091+13.7%+$1.84M0.08
Fort Washington Investment Advisors Inc Oh$15.26M0.35178,761New+$15.26M0.1
Retirement Systems of Alabama$15.29M0.35179,175+0.13%+$19,118.400.06
Prudential Financial$15.13M0.35177,294+2.89%+$424,872.300.02
Great Lakes Advisors®$14.3M0.33167,550-1.01%-$145,521.740.13
Arrowstreet Capital, Limited Partnership$14.3M0.33167,497+6%+$809,125.420.01
Goldman Sachs$13.75M0.32161,146-15.74%-$2.57M<0.01
RhumbLine Advisers$13.73M0.32160,819+0.46%+$63,244.210.01
Schwartz Investment Counsel Inc$12.89M0.3151,000+26.89%+$2.73M0.47
Oberweis Asset Management Inc$12.26M0.28143,695+35.72%+$3.23M0.89
PEREGRINE CAPITAL MANAGEMENT INC$11.49M0.27134,603+22.02%+$2.07M0.33
Deutsche Bank$11.26M0.26131,925-35.38%-$6.17M0.01
Emerald Advisers, Inc.$11.13M0.26130,437-11.46%-$1.44M0.45
AQR Capital$10.87M0.25128,775-7.3%-$855,866.380.02
SEI Investments Company$10.54M0.24123,487-3.09%-$336,186.750.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.